Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia
AM Dickinson, J Norden, S Li, I Hromadnikova… - Frontiers in …, 2017 - frontiersin.org
The success of hematopoietic stem cell transplantation (HSCT) lies with the ability of the
engrafting immune system to remove residual leukemia cells via a graft-versus-leukemia …
engrafting immune system to remove residual leukemia cells via a graft-versus-leukemia …
Long-term effects of pain in infants
Pain and stress have been shown to induce significant physiological and behavioral
reactions in newborn infants, even in those born prematurely. Infants who are born …
reactions in newborn infants, even in those born prematurely. Infants who are born …
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party …
HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein… - 1995 - ashpublications.org
The immune reactivity of allogeneic lymphocytes plays a major role in the control of
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
In allogeneic bone marrow transplantation (allo-BMT), donor lymphocytes play a central
therapeutic role in both graft-versus-leukemia (GvL) and immune reconstitution. However …
therapeutic role in both graft-versus-leukemia (GvL) and immune reconstitution. However …
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
CM Rooney, CYC Ng, S Loftin, CA Smith, C Li… - The Lancet, 1995 - Elsevier
Summary Reactivation of Epstein-Barr virus (EBV) after bone-marrow transplantation leads
in many cases to lymphoproliferative disease that responds poorly to standard therapy and …
in many cases to lymphoproliferative disease that responds poorly to standard therapy and …
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem, PP Lee, C Wang, K Felio, HM Kantarjian… - Nature medicine, 2000 - nature.com
Although the immune system has long been implicated in the control of cancer, evidence for
specific and efficacious immune responses in human cancer has been lacking. In the case …
specific and efficacious immune responses in human cancer has been lacking. In the case …
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of …
S Mackinnon, EB Papadopoulos, MH Carabasi… - 1995 - ashpublications.org
Infusions of large numbers (> 10 (8)/kg) of donor leukocytes can induce remissions in
patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We …
patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We …
[HTML][HTML] Graft-versus-myeloma effect: proof of principle
G Tricot, DH Vesole, S Jagannath, J Hilton, N Munshi… - Blood, 1996 - Elsevier
The presence of a graft-versus-tumor effect has been well established in leukemia but not in
multiple myeloma. A 40-year-old patient with myeloma refractory to standard chemotherapy …
multiple myeloma. A 40-year-old patient with myeloma refractory to standard chemotherapy …
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in …
PD Kottaridis, RE Gale, SE Langabeer… - Blood, The Journal …, 2002 - ashpublications.org
FLT3 mutations, either internal tandem duplications (ITDs) or aspartate residue 835 (D835)
point mutations, are present in approximately one third of patients with acute myeloid …
point mutations, are present in approximately one third of patients with acute myeloid …
[PDF][PDF] Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell …
P Bader, H Kreyenberg, W Hoelle… - Journal of clinical …, 2004 - researchgate.net
Purpose We recently reported that children with acute leukemias who show increasing
mixed chimerism (MC) after allogeneic stem-cell transplantation have a significantly …
mixed chimerism (MC) after allogeneic stem-cell transplantation have a significantly …